Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neumifil Phase 2a Influenza Challenge Study
NCT05507567Phase 2Completed
- Sponsor
- Pneumagen
- Start
- Aug 2022
- Primary completion
- May 2023
- Modality
- Inhalation Devices, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of HEX17 in influenza, sponsored by Pneumagen. Started Aug 2022; status: completed.
02
Drugs
HEX17
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05507567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05507567.